Sec Form 13G Filing - Sio Capital Management LLC filing for Bright Minds Biosciences Inc. (DRUG) - 2025-02-10

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  1 As of December 31, 2024, Sio Capital Management, LLC beneficially owned 451,793 shares of Common Stock with shared voting power and shared dispositive power.2 Based upon 6,948,489 Common Shares outstanding as of November 1, 2024, as disclosed to the Reporting Persons by the Issuer.


SCHEDULE 13G


 
Sio Capital Management, LLC
 
Signature:/s/ Jin W. Lee
Name/Title:Chief Compliance Officer
Date:02/07/2025
primary_doc.xml